Engineering macrophages to control the inflammatory response and angiogenesis

Area of Science:

• Immunology
• Cell Biology
• Biomedical Engineering

Background:

• Macrophage (MΦ) dysregulation is linked to inflammatory diseases like atherosclerosis and cancer.
• The distinct roles of pro-inflammatory (M1) and pro-healing (M2) MΦ phenotypes in tissue repair remain unclear.
• Temporal regulation of MΦ phenotype balance is crucial for resolving inflammation and achieving tissue homeostasis.

Purpose of the Study:

• To engineer a controllable MΦ cell line for studying the M1 phenotype.
• To investigate the temporal dynamics and inflammatory effects of activated M1-like MΦs.
• To establish a tool for isolating and observing the M1 MΦ phase in wound healing.

Main Methods:

• Engineered MΦ-cTLR4 cells activated by a chemical inducer of dimerization (CID).
• Assessed M1 marker expression (TNFα, IL-6, iNOS) and duration of activation.
• Evaluated CID-activated MΦ-cTLR4 effects on endothelial cells (ECs) for VCAM-1 and ICAM-1 upregulation.

Main Results:

• CID-activated MΦ-cTLR4 cells exhibited increased M1 markers and remained activated for at least 48 hours.
• MΦ-cTLR4 cells returned to baseline within 18 hours after CID withdrawal.
• Activated MΦ-cTLR4 cells induced TNFα-dependent upregulation of VCAM-1 and ICAM-1 on ECs.

Conclusions:

• Engineered MΦ-cTLR4 cells provide a controllable system to study M1 MΦ responses.
• This tool allows for the isolation of the M1 MΦ phase, aiding research into inflammatory processes.
• Understanding the M1 phase may reveal conditions necessary for optimal tissue healing and inflammatory resolution.